Amanda Stolarz

Amanda Stolarz, Pharm.D., Ph.D., is an Assistant Professor at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, Department of Pharmaceutical Sciences. Her research focuses on cardiovascular/lymphatic pharmacology, particularly the impact of cancer chemotherapy on lymphatic integrity and the development of therapeutic strategies to mitigate this damage. She also investigates the effects of cardiovascular drugs on lymphatic function, linking hypertension treatment to lymphedema risk in cancer patients.

• Education: B.S. in Chemistry (Arkansas Tech University), Pharm.D. (UAMS College of Pharmacy), Ph.D. in Pharmacology (UAMS Graduate School), Postdoctoral Fellowship in Pharmacology/Toxicology (UAMS).
• Teaching: Pharmacology I (PHSC 7201).

Her research integrates hypothesis-driven approaches with techniques including tissue dissection, flow cytometry, vascular functional studies, gene/protein expression assays, surgical lymph flow measurement, and high-speed optical imaging. Key areas include chemotherapy-induced lymphatic damage, antihypertensive drug effects, and lymphedema mechanisms.

Recent publications highlight her work on lymphatic flow preservation, drug-induced lymphatic dysfunction, and imaging methodologies. Collaborations with researchers like Rusch NJ and Zharov VP emphasize interdisciplinary translational studies.

While no awards or grants are explicitly detailed, her lab's focus on pharmacological interventions and lymphatic physiology underscores her contributions to drug development and vascular health.